Suppr超能文献

贝赫切特病的免疫发病机制。

Immunopathogenesis of Behçet's disease.

机构信息

New York University Grossman School of Medicine, Department of Medicine, New York, NY, USA.

New York University Grossman School of Medicine, Department of Medicine, New York, NY, USA; New York University Grossman School of Medicine, Department of Pathology, USA; New York University Grossman School of Medicine, Department of Medicine, Division of Rheumatology, NYU Langone Ocular Rheumatology Program, New York, NY, USA; New York University Grossman School of Medicine, Department of Medicine, Division of Rheumatology, NYU Langone Center for Behçet's Disease, New York, NY, USA.

出版信息

Clin Immunol. 2023 Aug;253:109661. doi: 10.1016/j.clim.2023.109661. Epub 2023 Jun 7.

Abstract

Behçet's disease (BD) is a multi-system inflammatory disorder with vasculitic features. It does not suit any of the current pathogenesis-driven disease classifications well, a unifying concept of its pathogenesis is not unanimously conceivable at present, and its etiology is obscure. Still, evidence from immunogenetic and other studies supports the notion of a complex-polygenic disease with robust innate effector responses, reconstitution of regulatory T cells upon successful treatment, and first clues to the role of an, as of yet, underexplored adaptive immune system and its antigen recognition receptors. Without an attempt to be comprehensive, this review aims to collect and organize impactful parts of this evidence in a way that allows the reader to appreciate the work done and define the efforts needed now. The focus is on literature and notions that drove the field into new directions, whether recent or more remote.

摘要

白塞病(BD)是一种多系统炎症性疾病,具有血管炎特征。它不太符合当前任何一种基于发病机制的疾病分类,目前还无法统一其发病机制的概念,其病因也不清楚。然而,免疫遗传学和其他研究的证据支持这样一种观点,即白塞病是一种复杂的多基因疾病,具有强大的固有效应器反应,在成功治疗后重建调节性 T 细胞,以及对尚未充分探索的适应性免疫系统及其抗原识别受体的作用的初步线索。本综述不试图面面俱到,旨在以一种让读者能够欣赏到已完成的工作并确定当前所需努力的方式,收集和整理这些证据中具有重要影响的部分。重点是推动该领域进入新方向的文献和概念,无论这些新方向是近期的还是更久远的。

相似文献

1
Immunopathogenesis of Behçet's disease.
Clin Immunol. 2023 Aug;253:109661. doi: 10.1016/j.clim.2023.109661. Epub 2023 Jun 7.
2
Behçet's disease risk-variant HLA-B51/ERAP1-Hap10 alters human CD8 T cell immunity.
Ann Rheum Dis. 2022 Nov;81(11):1603-1611. doi: 10.1136/ard-2022-222277. Epub 2022 Aug 3.
3
Dose HLA-B5, 7, 8, 27, and 51 Antigens Associated to Behcet's disease? A Study in Southwestern Iran.
Curr Rheumatol Rev. 2020;16(2):120-124. doi: 10.2174/1573397115666190918153721.
4
Behçet's disease: an update on the pathogenesis.
Clin Exp Rheumatol. 2001 Sep-Oct;19(5 Suppl 24):S6-12.
5
Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B* 5101.
Am J Ophthalmol. 1993 Oct 15;116(4):406-9. doi: 10.1016/s0002-9394(14)71396-0.
6
A strong association between HLA-B*5101 and Behçet's disease in Greek patients.
Tissue Antigens. 1997 Jul;50(1):57-60. doi: 10.1111/j.1399-0039.1997.tb02835.x.
7
Immunopathogenesis of Behçet's disease and treatment modalities.
Semin Arthritis Rheum. 2022 Feb;52:151956. doi: 10.1016/j.semarthrit.2022.151956. Epub 2022 Jan 10.
8
Genetics of Behçet's disease: lessons learned from genomewide association studies.
Curr Opin Rheumatol. 2014 Jan;26(1):56-63. doi: 10.1097/BOR.0000000000000003.
9
Primary association of HLA-B51 with Behçet's disease in Ireland.
Br J Ophthalmol. 1997 Aug;81(8):649-53. doi: 10.1136/bjo.81.8.649.

引用本文的文献

1
Neuro-Behçet's Disease in a Middle Eastern Male: A Rare and Challenging Diagnosis.
Cureus. 2025 Jun 9;17(6):e85628. doi: 10.7759/cureus.85628. eCollection 2025 Jun.
3
[Update on Behçet syndrome].
Z Rheumatol. 2024 Dec;83(10):822-828. doi: 10.1007/s00393-024-01576-x. Epub 2024 Oct 1.
4
Interpreting the Function of the IL-23/IL-17 Axis through Bioinformatics.
Endocr Metab Immune Disord Drug Targets. 2025;25(6):429-441. doi: 10.2174/0118715303316226240823045641.
5
Profile of immunological biomarkers in Behcet's syndrome: a large-scale single-center real-world study.
Clin Exp Med. 2024 Aug 28;24(1):201. doi: 10.1007/s10238-024-01462-5.
6
Decoding Behcet's Uveitis: an In-depth review of pathogenesis and therapeutic advances.
J Neuroinflammation. 2024 May 22;21(1):133. doi: 10.1186/s12974-024-03123-6.
7
Deficiency of peripheral CLA Tregs and clinical relevance in Behcet's syndrome.
Arthritis Res Ther. 2024 Mar 21;26(1):76. doi: 10.1186/s13075-024-03306-9.

本文引用的文献

1
Role of neutrophil interleukin-23 in spondyloarthropathy spectrum disorders.
Lancet Rheumatol. 2023 Jan;5(1):e47-e57. doi: 10.1016/S2665-9913(22)00334-4.
2
The proportion of C1q-high and ISG15-high monocytes in the skin of patients with Behçet disease.
Front Pharmacol. 2023 Mar 7;14:1110741. doi: 10.3389/fphar.2023.1110741. eCollection 2023.
3
5
Behçet's disease risk-variant HLA-B51/ERAP1-Hap10 alters human CD8 T cell immunity.
Ann Rheum Dis. 2022 Nov;81(11):1603-1611. doi: 10.1136/ard-2022-222277. Epub 2022 Aug 3.
6
Single-cell analyses highlight the proinflammatory contribution of C1q-high monocytes to Behçet's disease.
Proc Natl Acad Sci U S A. 2022 Jun 28;119(26):e2204289119. doi: 10.1073/pnas.2204289119. Epub 2022 Jun 21.
7
Granzyme K CD8 T cells form a core population in inflamed human tissue.
Sci Transl Med. 2022 Jun 15;14(649):eabo0686. doi: 10.1126/scitranslmed.abo0686.
8
Oral Health and Its Aetiological Role in Behçet's Disease.
Front Med (Lausanne). 2021 May 20;8:613419. doi: 10.3389/fmed.2021.613419. eCollection 2021.
9
Transmigration of Neutrophils From Patients With Familial Mediterranean Fever Causes Increased Cell Activation.
Front Immunol. 2021 May 17;12:672728. doi: 10.3389/fimmu.2021.672728. eCollection 2021.
10
Neutrophil Extracellular Traps Promote Aberrant Macrophages Activation in Behçet's Disease.
Front Immunol. 2021 Feb 5;11:590622. doi: 10.3389/fimmu.2020.590622. eCollection 2020.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验